Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] PCSL is engaged in manufacturing and marketing of specialty chemicals with a prime focus on cellulose-based excipients. The company has created a niche place in this segment with domestic and international markets. The company posted steady growth in its top and bottom lines. Higher net margins from FY24 onwards have surprised all. Based on its recent financial data, the issue appears fully priced. Well-informed investors may park funds for medium to long term. Read detail review...
Patel Chem Specialities Ltd. peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Patel Chem Specialities Limited | 6.10 | 6.10 | 20.44 | 29.85 | |||
| Accent Microcell Limited | 15.71 | 15.71 | 92.57 | 16.26 | 16.97 | Consolidated | |
| Sigachi Industries Limited | 2.06 | 2.06 | 15.72 | 20.51 | 11.73 | 3.67 | Consolidated |
Notes:
Patel Chem Specialities IPO Reviews, analysis and views by popular members. Read Patel Chem Specialities Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP